Human CD30 Antibody (Brentuximab, Research Use)

产品名称	Human CD30 Antibody (Brentuximab, Research Use)
目录号	NBR-0014
别名	TNFRSF8; D1S166E
外观	Transparent Liquid
分子量	150kDa
CAS	N/A
溶解度	Water, PBS, TBS Buffer,etc.
存储条件	Temp. -80℃
保存时间	see COA
备注1	CHO Expressed
备注2	Ab. Isotype - IgG

目录号	规格	价格	库存状态
NBR-0014-100UG	100ug	￥550	请咨询
NBR-0014-1MG	1mg	￥3500	请咨询
NBR-0014-5MG	5mg	￥7500	请咨询

【产品概况】

产品名称：Human CD30 Antibody (Brentuximab, Research Use)
产品编号：NBR-0014
针对靶点：CD30
抗体药商品名：Brentuximab
抗体药描述：Brentuximab vedotin (INN; trade name Adcetris) is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma (HL) and systemic anaplastic large cell lymphoma (ALCL), a type of T cell non-Hodgkin lymphoma.

【产品参数】

产品外观：Transparent Liquid
分子量：~150kDa
CAS：N/A
溶解度：Water; PBS, TBS Buffer等
表达系统：CHO Expressed
抗体亚型：Ab. Isotype - IgG

【基因信息】

Gene Name: CD30
Synonyms: TNFRSF8; D1S166E
Target Description: Receptor for TNFSF8/CD30L. May play a role in the regulation of cellular growth and transformation of activated lymphoblasts. Regulates gene expression through activation of NF-kappa-B.
Ensembl: ENSG00000120949
Uniprot: P28908